UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemodynamic Effects of Fenofibrate and Coenzyme Q₁₀ in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction

Diabetes care, 2008-08, Vol.31 (8), p.1502-1509

2008

Volltextzugriff (PDF)

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

The journal of clinical endocrinology and metabolism, 2021-04, Vol.106 (4), p.e1917-e1918

2021

Volltextzugriff (PDF)

Letter to the Editor: “Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia”

The journal of clinical endocrinology and metabolism, 2019-02, Vol.104 (2), p.461-462

2019

Volltextzugriff (PDF)

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Human reproduction (Oxford), 2008-10, Vol.23 (10), p.2352-2358

2008

Volltextzugriff (PDF)

Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?

Fertility and sterility, 2016-10, Vol.106 (5), p.1258-1263

2016

Volltextzugriff (PDF)

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Metabolism, clinical and experimental, 2014-08, Vol.63 (8), p.1071-1077

2014

Volltextzugriff (PDF)

Thyroxine replacement during super-ovulation for in vitro fertilization: a potential gap in management?

Fertility and sterility, 2010-05, Vol.93 (7), p.2414.e1-2414.e3

2010

Volltextzugriff (PDF)

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes : Results of a randomized controlled trial

Diabetes care, 2003-02, Vol.26 (2), p.279-284

2003

Volltextzugriff (PDF)

The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention

Nature clinical practice cardiovascular medicine, 2007-05, Vol.4 (5), p.263-273

2007

Volltextzugriff (PDF)

Erectile dysfunction predicts generalised cardiovascular disease: Evidence from a case–control study

Atherosclerosis, 2007-10, Vol.194 (2), p.458-464

2007

Volltextzugriff (PDF)

Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy?

Urology (Ridgewood, N.J.), 2003-10, Vol.62 (4), p.727-731

2003

Volltextzugriff (PDF)

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Medical journal of Australia, 2022-04, Vol.216 (6), p.283-284

2022

Volltextzugriff (PDF)

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2022-11, Vol.400 (10364), p.1704-1711

2022

Volltextzugriff (PDF)

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Medical journal of Australia, 2011-09, Vol.195 (6), p.S65-S112

2011

Volltextzugriff (PDF)

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

The journal of clinical endocrinology and metabolism, 2023-12, Vol.108 (12), p.e1560-e1570

2023

Volltextzugriff (PDF)

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Menopause (New York, N.Y.), 2023-04, Vol.30 (4), p.427

2023

Volltextzugriff (PDF)

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

The journal of clinical endocrinology and metabolism, 2009-10, Vol.94 (10), p.3842-3848

2009

Volltextzugriff (PDF)

Non-hormonal treatments for menopausal symptoms

Maturitas, 2007-05, Vol.57 (1), p.85-89

2007

Volltextzugriff (PDF)

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Medical journal of Australia, 2016-08, Vol.205 (4), p.173-178

2016

Volltextzugriff (PDF)

Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome

Fertility and sterility, 2008-12, Vol.90 (6), p.2298-2303

2008

Volltextzugriff (PDF)

Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

The journal of clinical endocrinology and metabolism, 2023-12, Vol.109 (1), p.e25-e31

2023

Volltextzugriff (PDF)

Establishing a Total Hip T-Score Threshold to Measure Contralateral Hip Bone Mineral Density: Avoiding Missed Diagnosis of Osteoporosis

Journal of clinical densitometry, 2022-10, Vol.25 (4), p.577-586

2022

Volltextzugriff (PDF)

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

European journal of endocrinology, 2023-07, Vol.189 (1), p.50-57

2023

Volltextzugriff (PDF)

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

European journal of endocrinology, 2022-01, Vol.186 (3), p.307-318

2022

Volltextzugriff (PDF)

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

European journal of human genetics : EJHG, 2016-02, Vol.24 (2), p.284-290

2016

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hemodynamic Effects of Fenofibrate and Coenzyme Q₁₀ in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

Letter to the Editor: “Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia”

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Thyroxine replacement during super-ovulation for in vitro fertilization: a potential gap in management?

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes : Results of a randomized controlled trial

The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention

Erectile dysfunction predicts generalised cardiovascular disease: Evidence from a case–control study

Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy?

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

Non-hormonal treatments for menopausal symptoms

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome

Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

Establishing a Total Hip T-Score Threshold to Measure Contralateral Hip Bone Mineral Density: Avoiding Missed Diagnosis of Osteoporosis

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

Suchergebnisse filtern